Expression and Function of ABC Transporters as Multidrug Resistance Mechansims in Gastric Cancer Cells.
- Author:
Seong Pyo MOON
1
;
Kyung Jong KIM
;
Young Don MIN
;
Tae Bum LEE
;
Kwon Ryul JUNG
;
Jae Up LEE
;
Cheol Hee CHOI
Author Information
1. Department of Surgery, Chosun University College of Medicine, Gwangju, Korea. kjkim@chosun.ac.kr
- Publication Type:Original Article
- Keywords:
Gastric cancer cells;
Multidrug resistance (MDR);
ABC transporters
- MeSH:
Antineoplastic Agents;
ATP-Binding Cassette Transporters*;
Breast;
Drug Resistance, Multiple*;
Etoposide;
Flow Cytometry;
Membrane Transport Proteins;
Membranes;
P-Glycoprotein;
Paclitaxel;
Prevalence;
Probenecid;
RNA, Messenger;
Stomach Neoplasms*
- From:Journal of the Korean Surgical Society
2005;68(5):359-366
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Multidrug resistance (MDR) is a phenomenon whereby tumor cell acquire resistance to a broad range of structurally and functionally diverse chemotherapeutic drugs. The most widely implicated mechanism of MDR is that of altered membrane transporter in tumor cells. P-glycoprotein (Pgp), multidrug resistance protein (MRP), and breast cancer-resistance protein (BCRP) are well known membrane transporters, which pump out antitumor agents via an ATP-dependent process, the so called ATP-binding cassette (ABC) superfamily or transporter. This study was undertaken to test the prevalence of each ABC transporter, and which of then exhibit functional activity in various gastric cancer cells. METHODS: The expressions of Pgp, MRP, and BCRP mRNA were determined by RT-PCR assay on 10 gastric cancer cells. The sensitivity to anticancer agents, substrates for each ABC transporter in the gastric cancer cells was determined using the MTT assay. The intracellular accumulation of fluorescent compounds for the functional detection of each ABC transporter was determined using flow cytometry. RESULTS: The Pgp mRNA was expressed at various levels in 9 out of the 10 gastric cancer cells tested, but significantly low. MRP mRNA was constitutively expressed in all the cells. BCRP mRNA was differentially expressed in 5 of the gastric cancer cells. There was no relation between the expressions of Pgp and MRP and the cytotoxicity to each substrate. It was observed that the accumulations of paclitaxel and VP-16 were significantly increased on the additions of PSC833 and probenecid, respectively, in all tested cells. The reversal effect of drug accumulation by each inhibitor was much higher in the MRP than Pgp. With BCRP, the observed cytotoxic effect and amount of mitoxanthrone accumulation were less than in the cells expressing the highest levels of BCRP compared to those that did not. However the mitoxanthrone accumulation was not increased on the addition of FTC in the either cell type. CONCLUSION: This study suggests that of the ABC transporters, MRP has primarily functional activity, whereas that of Pgp is only slight, in the gastric cancer cells. Other possible MDR mechanisms involved will have to be explored in further studies.
